Your session is about to expire
← Back to Search
Weight Loss for Kidney Stones
Study Summary
This trial will test if weight loss can help reduce the amount of oxalate produced by the body, which may help prevent calcium oxalate kidney stones.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My last kidney stone was passed or removed over 3 months ago.I do not have uncontrolled high blood pressure or recent serious heart issues.I have a history of conditions like hyperparathyroidism or cystic fibrosis.I do not have cirrhosis, pancreatic/biliary disorders, porphyria, or gout.I have no vacations planned in the next 4 months.I have been treated for cancer within the last year.I do not have nephrotic syndrome, neurogenic bladder, or urinary diversion.Your hemoglobin A1C level is lower than 6.5%.You drink more than 12 alcoholic drinks a week and are not willing to stop drinking for 2 days before and during the study.I have a stomach or intestine condition or had surgery affecting oxalate in my body.I have not had a fever or flu-like symptoms, including COVID-19, in the last 21 days.I have a condition that causes high oxalate levels in my urine.My most recent kidney stone was mostly calcium oxalate.You have a BMI higher than 35, which means you are severely overweight.Your blood test results for sodium, potassium, chloride, carbon dioxide, calcium, albumin, AST, ALT, and glucose are within normal range, and your kidney function is good.My kidney function tests are within the normal range for my gender.My blood pressure is controlled and below 160/90 mmHg.I am willing to stop taking stone prevention meds and supplements for 14 days before and during the study.My cholesterol and triglyceride levels are within safe ranges.It's okay if you smoke, chew tobacco, or vape.I am not taking topiramate, acetazolamide, zonisamide, diuretics, SGLT2-inhibitors, or immunosuppressants.I have type 2 diabetes or my A1c level is 6.5% or higher.My kidney function is reduced, with an eGFR below 60.I have had kidney stone pain or surgery in the last 3 months.
- Group 1: Controlled Diet and Weight Loss Program
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there still open opportunities for individuals to participate in this experiment?
"Per information on clinicaltrials.gov, the trial is presently recruiting individuals; records suggest that it was initially listed on December 3rd 2021 and most recently revised on February 14th 2022."
What is the sample size of participants in this research experiment?
"Affirmative. According to clinicaltrials.gov, this medical trial – which was originally published on December 3rd 2021 - is still in the process of enlisting volunteers. 36 individuals are required from a single site for enrollment into the study."
Are those aged 25 and above eligible for participation in this experiment?
"This medical trial requires that all participants are between 19 and 65 years of age. If a person is younger than 19 or older than 65, they may be eligible to join one of the 25 trials designated for minors or 251 studies tailored towards senior citizens."
For whom is this clinical trial most appropriate?
"This trial is recruiting 36 participants with kidney stones aged between 19 and 65. If you meet these criteria, you may be eligible to join this medical study."
Share this study with friends
Copy Link
Messenger